ASCEND BY NTHRYS
Research Abroad Products

Applied Immunology Project Topics

Browse all focused areas across all project categories under this field.

Showing 73–84 of 200 project topics
Decentralized Allogeneic NK Cell Production Technology Stack
A modular manufacturing system designed for regional off-the-shelf NK cell production at satellite facilities, leveraging proprietary expansion and cryopreservation protocols for immediate clinical deployment. This distributed model captures $500M+ annual market opportunity by eliminating patient-specific customization costs and enabling same-day therapeutic availability across hospital networks.
Immune Cell Therapy Development & Manufacturing Click to view more details →
T Cell Receptor Engineering Design-to-Manufacture Software
A software-as-a-service platform enabling rapid in-silico design, synthesis optimization, and manufacturing protocol generation for engineered T cell receptors with predictive models for clinical efficacy. This reduces development cycles from 18 months to 4-6 months and supports licensing partnerships worth $50M+ per engineered TCR program.
Immune Cell Therapy Development & Manufacturing Click to view more details →
Point-of-Care Immune Cell Expansion and Conditioning Unit
A benchtop-scale, fully integrated device that performs cell isolation, expansion, genetic modification, and cryopreservation within a single closed system for bedside or clinic-based deployment. This creates a recurring revenue model through disposable cartridges ($8,000-12,000 per patient) while eliminating centralized manufacturing bottlenecks and capturing urgent-care immunotherapy markets.
Immune Cell Therapy Development & Manufacturing Click to view more details →
Regulatory Compliance and Data Management Platform for Cell Therapies
An enterprise SaaS solution providing electronic batch records, traceability, adverse event tracking, and automated regulatory reporting for cell therapy manufacturers pursuing FDA, EMA, and PMDA approvals. This reduces compliance audit preparation time by 70% and enables multi-jurisdictional submissions, generating licensing revenue and reducing regulatory delay penalties.
Immune Cell Therapy Development & Manufacturing Click to view more details →
Immunogenicity Prediction Engine for Personalized Cell Therapies
A bioinformatics platform analyzing patient HLA profiles and tumor microenvironments to predict optimal allogeneic or autologous cell therapy compositions and predict rejection risk pre-manufacturing. This reduces failed infusions by 35% and enables a companion diagnostic revenue stream ($2,000-5,000 per patient) while improving clinical trial success rates.
Immune Cell Therapy Development & Manufacturing Click to view more details →
Scale-Out Bioreactor Orchestration and Control Software System
A unified digital platform managing parallel bioreactors, process parameters, and cross-batch consistency for immunotherapy manufacturing at clinical and commercial volumes without proportional cost increases. This enables 500%+ capacity expansion with linear capital costs and positions manufacturers for $100M+ annual cell therapy revenue.
Immune Cell Therapy Development & Manufacturing Click to view more details →
Ex Vivo Immune Cell Potency and Persistence Biomarker Platform
A high-throughput functional assay platform paired with machine learning algorithms predicting in-vivo efficacy and durability of engineered immune cells from brief ex-vivo testing protocols. This monetizes as a diagnostic service ($5,000-8,000 per product candidate) and accelerates clinical trial designs by enriching for durable responder cohorts.
Immune Cell Therapy Development & Manufacturing Click to view more details →
Cold-Chain Logistics and Viability Monitoring IoT Network
An integrated hardware-software platform using passive temperature sensors, blockchain tracking, and real-time viability forecasting to ensure cell therapy integrity throughout supply chains from manufacturing to patient infusion. This reduces product loss by 12-18% and commands $50-150K annual contracts per institution while capturing contractual liability insurance savings.
Immune Cell Therapy Development & Manufacturing Click to view more details →
Real-Time Multiplexed Cytokine Detection Platform
A cloud-integrated hardware and software platform that simultaneously measures 50+ cytokines from patient samples using advanced immunoassay technology. Enables laboratories to reduce turnaround time by 60% and monetize through subscription-based licensing and per-sample analysis fees.
Cytokine & Chemokine Profiling Service Platforms Click to view more details →
AI-Powered Chemokine Biomarker Discovery SaaS
A machine learning platform that analyzes chemokine expression patterns across disease cohorts to identify novel diagnostic and prognostic biomarkers. Generates recurring revenue through enterprise licensing and enables pharma clients to de-risk clinical trial investments by 40%.
Cytokine & Chemokine Profiling Service Platforms Click to view more details →
Automated High-Throughput Cytokine Profiling Workstation
An integrated robotic system that processes 384-well plates with full immunological profiling in under 4 hours, including data analysis and reporting. Creates hardware-as-a-service revenue models and reduces per-sample operational costs by 70% for clinical labs.
Cytokine & Chemokine Profiling Service Platforms Click to view more details →
Portable Point-of-Care Chemokine Testing Cartridge System
A disposable microfluidic cartridge system paired with a handheld analyzer that delivers cytokine/chemokine results in under 15 minutes at bedside or remote locations. Captures emergency diagnostics and field testing markets worth $2.3B annually with recurring cartridge consumables revenue.
Cytokine & Chemokine Profiling Service Platforms Click to view more details →